Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma. Zhang Y, Zhang T, Zhao Y, Wu H, et al. BMC Cancer 2023;23:759.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang Y, Zhang T, Zhao Y, Wu H, et al. Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma. BMC Cancer 2023;23:759.
PMID: 37587457